Plan your weekend getaway with these affordable options!
Plan your weekend getaway with these affordable options!
France’s government is holding emergency virus meetings Tuesday and warning of possible new lockdowns, as hospitals fill up with new COVID patients and doctors plead for backup. President Emmanuel Macron is convening top ministers and Prime Minister Jean Castex is meeting with lawmakers, unions and business lobbies as the government weighs its next steps in the fight against surging infections. Interior Minister Gerald Darmanin told France-Inter radio that “we should expect difficult decisions.”
The Chinese economy is expected to grow at its slowest pace in over four decades despite its recovery from COVID-19, according to a Reuters poll.
Euro zone companies continued to load up on bank credit last month, bracing for a second wave of the coronavirus pandemic that is raising fears of new economic restrictions and a double-dip recession, European Central Bank data showed on Tuesday. With much of the euro zone economy shut down amid the pandemic, firms rushed to tap emergency credit lines this year, supported by government guarantees and central bank funding available for rates as low as minus 1%.
Dublin, Oct. 27, 2020 (GLOBE NEWSWIRE) -- The "United States Phenol Market Analysis, Plant Capacity, Production, Operating Efficiency, Technology, Demand & Supply, End User Industries, Distribution Channel, Region-Wise Demand, Import & Export , 2015-2030" report has been added to ResearchAndMarkets.com's offering. The United States Phenol industry has shown remarkable growth in the past five years and is anticipated to grow at a CAGR of 4.6% during the forecast period. Bisphenol A is the largest end-user industry, holding more than 45% of the total US Phenol demand. Growing demand for polycarbonates from automotive, construction, and electronic sectors driven by the country's strong economic growth would further support the market growth in the forecast period.This report includes US Phenol market demand and supply analysis on a cloud-based platform for one year. The data is updated on near real time basis to add any new movement in the industry including but not limited to new plant announcement, plant shutdowns, temporary disruptions in the demand or supply, news and deals and much more specific to Phenol.Years Considered for Analysis: Historical Years: 2015 - 2018Base Year: 2019Estimated Year: 2020Forecast Period: 2021 - 2030 Deliverables: Installed Capacity By Company: Installed capacity within the country along with individual capacity of leading playersInstalled Capacity By Location: Installed capacity at several locations across the countryInstalled Capacity By Process: Installed capacity by different processesInstalled Capacity By Technology: Installed capacity by different technologies being used to produce PhenolProduction By Company: Actual production done by different companiesOperating Efficiency By Company: Operating efficiency at which different companies are operating their plantsDemand By End-Use: Demand/Sale of Phenol in different end-user industries across the countryDemand By Sales Channel: Demand/Sale of Phenol by different sales channels across the countryDemand By Region: Demand/Sale of Phenol in different regions of the countryCountry Wise Exports: Exports of Phenol by Different CountriesCountry Wise Imports: Imports of Phenol by Different CountriesDemand & Supply Gap: Demand & Supply Gap at country levelMarket Share of Leading Players: Revenue shares of leading players in the countryNews & Deals: Historical & Current News & Deals in the Phenol market Key Topics Covered: US Phenol Market Outlook, 2015-2030 Capacity By CompanyCapacity By LocationCapacity By ProcessCapacity By TechnologyProduction By CompanyOperating Efficiency By CompanyDemand By End Use (Phenolic Resin, Bisphenol A, Pharmaceuticals, and Others)Demand By Sales Channel (Direct/Institutional Sales, Retail Sales, Other Channel Sales)Demand By RegionCountry Wise ExportsCountry Wise ImportsDemand & Supply GapMarket Share of Leading PlayersNews & Deals For more information about this report visit https://www.researchandmarkets.com/r/xb7m45 About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The 52-year-old BBC news reader had said she would break the lockdown restrictions in order to celebrate Christmas with all of her family together.
In between vice president and presidential nominee, Joe Biden held a different honorary title in the Democratic Party: chief surrogate.In 2018, Biden was one of the most sought-after voices on the stump for down-ballot candidates, helping Democrats score Republican seats and win the House majority, while quieting cheers for his own eventual presidential run. Now, cautious not to replay the tactical and mathematical fiascos that made Hillary Clinton concede swaths of the country to Donald Trump, the former vice president has filled his closing itinerary with places like Southfield, Michigan and Bucks County, Pennsylvania. He’ll be in Florida on Thursday and Wisconsin on Friday.But some local party officials and strategists are hoping for more. In the final week, they are urging Biden to reach beyond top-ticket battlegrounds and are making the explicit case that his star power should also be used to help sway the Senate races that could totally realign the power structure in Washington in January.“We’re trying to play a game without a quarterback,” said Dave Nagle, a former Democratic congressman from Iowa, in an interview late Monday morning.There, Democratic Senate nominee Theresa Greenfield is running neck-and-neck against junior Sen. Joni Ernst, the Republican incumbent, and, according to Nagle, a Biden visit could make a significant difference in the close.“The Biden campaign should come here for two reasons: First of all, it will help the Greenfield campaign, and secondly, it forces the GOP to spend resources here which they don’t have,” Nagle said, sharing other Democrats’ murmurs in private. “Even if he just flies into the airport and flies out, I think his presence would be a tremendous boost here.”It appears Bidenworld was listening. By 4 p.m., his campaign announced that he would enter the state on Friday with “additional details to follow,” marking his first physical general election trip.At the presidential level in Iowa, Biden is leading Trump by a hair in current averages, a once unfathomable possibility that gives Democrats optimism before Nov. 3. In 2016, candidate Trump won Iowa by 9 percentage points.Greenfield has fashioned her bid around a localized version of Biden’s national unity pitch. In advertisements, she promises to work in a bipartisan manner, dovetailing with the former vice president’s argument that he is poised to bring both parties together during an extended period of hardship.“They really are pretty well aligned in terms of what their agendas are and what their message is,” said Peter Leo, who chairs the Carroll County Democrats.MAGA Fans Tie Susan Collins to Trump Whether She Likes It or NotDuring the midterm elections, Biden successfully campaigned for Rep. Abby Finkenauer, who is generally considered the favorite to win her re-election bid for a second House term in the first congressional district. To return the favor, Finkenauer was one of Biden’s youngest and earliest endorsers ahead of the caucus. This time, Greenfield is in a much higher-profile race that some state Democrats believe could foreshadow other Midwestern outcomes on Election Day.“President Trump isn’t coming to the Hawkeye State to offer words of comfort to those suffering, or a helping hand to the Iowans who are out of a job, or an actual plan to get the virus under control. Instead, he’s here to spread more lies about the pandemic and distract from his record of failure,” Biden said in a statement before the president’s stop on Oct. 14.Before his expected landing, the Biden campaign had already devoted some resources to Iowa, which voted in favor of former President Barack Obama in both of his elections before handing power to Trump. Campaign organizers and surrogates have held virtual events with local officials, and Dr. Jill Biden is expected to arrive on Tuesday.While Iowa Democrats have been granted their wish, others in states with similar down-ballot implications are still standing by.One of those places is Maine. Republican Sen. Susan Collins has at times closely sided with Trump, while still managing to keep a distance with her embattled re-election campaign in mind. That on-again, off-again tension came into view on Sunday night, when she said she would vote against Amy Coney Barrett, the president’s latest Supreme Court nominee, because she disagreed with the timing of the confirmation.Recent polls show Collins’ Democratic challenger, House Speaker Sara Gideon, up an average of 4 percentage points. In one survey conducted by Pan Atlantic Research earlier this month, she was up by 7 points.“Maine—there are only five days left to vote early in-person for @SaraGideon and Democrats up and down the ballot. Sara has been a relentless champion for Mainers, and electing her is key to flipping the Senate—but we can’t do it without you,” Biden tweeted recently.Polling and party operatives suggest that Biden is likely to win at the top of the ticket in Maine, which divides its two allotted electoral votes. Like Iowa, Jill Biden is also expected to head to the state on behalf of her husband. But the Trump campaign, despite showing signs of slippage for months, has not stopped competing to hold on to the electoral vote it won over Clinton. That sentiment was reinforced over the weekend, when Trump made a stop in Levant, a town in the second congressional district, after rallying in neighboring New Hampshire.“The Biden campaign here is important for Speaker Gideon,” said David Farmer, a seasoned Democratic strategist and managing director of the Bernstein Shur Group. “Maine voters have had a history of splitting their ticket, particularly when it comes to Sen. Collins. She’s won by large margins because she’s been able to build in the past a coalition that included Republicans, Democrats, and independents. The key to this race for her is whether or not she can hold on to enough of those independent voters and Democratic voters in the current political environment.”“If the vice president and Sara Gideon were at the same venue, it could have a big impact,” Farmer said.He could also theoretically help undecided voters learn details about her record, who unlike four-term Collins, is still somewhat unknown to some residents. “If he could help elucidate the different points about the candidates, Biden could be really helpful,” said Elizabeth Rosen, the Maine communications director for NextGen America. “Biden is great at talking to people.”With an eye towards bigger prizes, the Biden campaign recently announced plans for the vice president to travel to Georgia and Florida, building up to what some Democrats hope will be a voyage through the Sunbelt. Georgia Senate candidate Jon Ossoff, who is strongly competing against Trump ally and first-term Republican Sen. David Perdue, said he was “encouraged” by Team Biden’s efforts to expand progress made in 2018. Making the rounds on network news, he asked for more engagement.“We’ve been really encouraged by the investments,” Ossoff told NBC News’ Chuck Todd last week about the Biden campaign. “But the bottom line is we always need more resources for voter protection here.” On Monday, Biden endorsed both Ossoff and Rev. Raphael Warnock, a Democratic candidate in the state’s special Senate election against Sen. Kelly Loeffler and Rep. Doug Collins, both Republicans. His campaign also announced that he will speak in Warm Springs and host a “drive-in” rally in Atlanta on Tuesday.Back in February just across the border, South Carolina Democrats proudly helped save Biden’s bid. Showing up to promote the party’s Senate nominee Jaime Harrison, who emerged as a formidable fundraiser after bringing in $57 million in the last quarter of the election, could help the ongoing effort to oust longtime Republican Sen. Lindsey Graham (R-SC).“Generally speaking, having a Democratic candidate for president come to South Carolina in the general election is not a good idea, but this is not a regular year,” said Don Fowler, a prominent figure in Democratic politics in the Palmetto State. “If I had to make a decision about having vice president Biden come to South Carolina in the next week, I would say do it.”“If you focus strictly on the Senate race, I would say that would be a good idea,” he concluded.Others, however, warned about devoting crunch time to places without much potential for presidential success. To win, Harrison is likely to need a bigger coalition of voters than just straight-ticket Democrats, they say, including those who may vote for a second Trump term.“I’d love to see him here, but pragmatically I’d love to see him elected president of the United States,” said Dick Harpootlian, an elected official and Biden confidant. “Now, if he can make it happen, great. I’m not discouraging it, I’m just saying based on seven days left … if he were to come he’d have to come relatively soon.”“If he could just stop here on the way down it would not hurt anything,” he said.Perhaps the biggest mystery is Texas, where Democrats have been talking for ages about the upshot of having Biden on their turf. The Democratic National Committee has developed a “coordinated” program with the Senate and House campaign arms to help Senate nominee M.J. Hegar defeat Republican Sen. John Cornyn and several congressional candidates. In the last days, Democrats are forcefully asking for Biden to show up in person.“Joe Biden coming to Texas would be huge,” said Kim Collins Gilby, the Democratic Party chairwoman in Williamson County. “If he could squeeze in a trip to Texas it would definitely help because we do have other congressional races,” she said, continuing that it “could really seal the deal for several people across the state.”Some polls are more optimistic for Hegar than others. A Quinnipiac survey from mid-October shows Cornyn at 49 percent, with Hegar at 43 percent. But the latest New York Times/Siena poll released on Monday indicates a tougher reach, with Cornyn leading by 10 points.Still, Biden’s top surrogates, including his running mate Sen. Kamala Harris (D-CA) are diving in after former Rep. Beto O’Rourke (D-TX) and former San Antonio Mayor JuliánCastro begged the campaign to show some facetime, according to a story by the Dallas Morning News.“My own sense is that Biden has a good chance of carrying the state now, it’s just a question of does he carry it by enough to drag some other folks across the finish line,” said Kier Murray, a top Democratic strategist in Houston. “A visit from him would really help to juice it even more and I think give other candidates an opportunity to be successful as well.”Read more at The Daily Beast.Get our top stories in your inbox every day. Sign up now!Daily Beast Membership: Beast Inside goes deeper on the stories that matter to you. Learn more.
Italy's main medicines regulator gave the go-ahead on Tuesday for human clinical trials on raloxifene, a generic osteoporosis drug that researchers hope may also help reduce COVID-19 symptoms and make patients less infectious. The drug was identified as a potential COVID-19 treatment by researchers using supercomputers to screen more than 400,000 molecules for chemical characteristics that might inhibit the virus, focusing on those already approved for use in humans. "It inhibits virus replication, thus preventing the worsening of patients with mild symptoms, and also decreases infectivity, limiting the viral load," said Marco Allegretti, head of research at Dompé Farmaceutici.
Tens of thousands of protesters marched through the Bangladesh capital on Tuesday calling for a boycott of French products and burning an effigy of President Emmanuel Macron after he defended cartoons depicting the Prophet Mohammed. Police estimated that more than 40,000 people took part in the march organised by an Islamist party, which was halted before it could get close to the French embassy in Dhaka.Hundreds of officers used a barbed-wire barricade to stop the protesters who broke up without violence.The French leader has been the target of protests in several countries over his comments, made after a teacher was decapitated for showing the cartoons to his pupils.The rally was organised by Islami Andolon Bangladesh (IAB), one of the country's largest Islamist parties, and started at Bangladesh's biggest mosque.Protesters chanted "Boycott French products" and called for Macron to be punished."Macron is one of the few leaders who worship Satan," Ataur Rahman, a senior Islami Andolon member told the rally at the Baitul Mukarram national mosque.Rahman called on the Bangladesh government to "kick out" the French ambassador while another leader, Hasan Jamal, said activists would "tear down every brick of that building" if the envoy was not ordered out."France is the enemy of Muslims. Those who represent them are also our enemies," said Nesar Uddin, a young leader of the group.Even after the rally was halted, demonstrators marched down other streets chanting "Boycott France" and "Macron will pay a high price".The French president's comments on Islam have already led to a diplomatic showdown with Turkey. Macron said the school teacher "was killed because Islamists want our future".(AFP)
Who would you expect to drive policy and public opinion when it comes to child hunger and poverty? A government, whose job it is to protect and care for its citizens, or a professional football player, whose job is it to score goals?In Britain, the answer is the professional footballer. “Marcus: The Pride of Britain” the Mirror’s front page read Monday, revealing the footballer Marcus Rashford had been given one of their “Pride of Britain” awards.Rashford, a forward for Premier League club Manchester United and the England national team, has led a hugely successful campaign, starting last spring, to ensure children no longer receiving free school meals during the pandemic are fed. His inspirational activism has, in the past, forced the government to act. Now the government insists it will not be moved again; they say they will not fund the meals that 1.3 million children—thought to be closer to 2 million during the pandemic—rely on. He knows their situations all too well—as a child, he was one of them.Five Ex-Prime Ministers Round on ‘Shameful’ Boris Johnson as He Plots to Break International LawThe footballer initially partnered with the charity FareShare to feed 400,000 children in the Greater Manchester area; that campaign’s success soon translated to a national campaign reaching an estimated four million children and galvanized a surge in donations, fundraising, and community activism. Earlier this month the Queen made Rashford an MBE (Member of the British Empire) in recognition of his work.“Food poverty in England is a pandemic that could span generations if we don’t course correct now,” Rashford wrote in an open letter to the government in June. “Whilst 1.3 million children in England are registered for free school meals, one quarter of these children have not been given any support since the school closures were ordered.”The day after the letter was published, the government announced it was extending the provision of free school meals for children through the summer holidays. A subsequent petition Rashford started to extend the scheme through to next Easter (including the October half-term holiday) garnered enough signatures to force Parliament to debate—and vote—on the issue. But the proposal was defeated, 322 votes to 261, in Parliament last week.“Put aside all the noise, the digs, the party politics, and let’s focus on the reality,” Rashford tweeted afterward. “A significant number of children are going to bed tonight not only hungry but feeling like they do not matter because of comments that have been made today,” Rashford wrote, adding, “We must stop stigmatizing, judging and pointing fingers. Our views are being clouded by political affiliation. This is not politics, this is humanity… “I don’t have the education of a politician, many on Twitter have made that clear today, but I have a social education having lived through this and having spent time with the families and children most affected. These children matter.” He said he wanted to sit down with Prime Minister Boris Johnson and politicians to formulate solutions.> Time we worked together. pic.twitter.com/xFPsgBiPQC> > — Marcus Rashford MBE (@MarcusRashford) October 21, 2020There is now widespread anger, and a rebellion within the government’s own ranks, over the vote and how it brutally confirms the historic perception that the Tories are the “nasty” party, never happier than when overseeing cuts in services and support to those who need it most. In their defense, Johnson’s government say they have expanded free school meal provision, increased welfare support by 9.3 billion pounds ($12.1 billion), and made 63 million pounds ($82 million) available to councils for families facing financial difficulties.Johnson has said, “I totally understand the issue of holiday hunger; it is there, we have to deal with it. The debate is how do you deal with it.” He has also hailed Rashford’s work as “terrific.” His ministers claim it is not the government’s job to feed in-need children during the school holidays. The more they say it, the crueler they sound.In June, when Rashford issued his open letter to the government, he made clear how personal the mission was.“My story to get here is all-too-familiar for families in England: my mum worked full-time, earning minimum wage to make sure we always had a good evening meal on the table. But it was not enough. The system was not built for families like mine to succeed, regardless of how hard my mum worked,” Rashford wrote.“As a family, we relied on breakfast clubs, free school meals, and the kind actions of neighbors and coaches. Food banks and soup kitchens were not alien to us; I recall very clearly our visits to Northern Moor to collect our Christmas dinners every year. It’s only now that I really understand the enormous sacrifice my mum made in sending me away to live in digs aged 11, a decision no mother would ever make lightly.”He continued: “As a black man from a low-income family in Wythenshawe, Manchester, I could have been just another statistic. Instead, due to the selfless actions of my mum, my family, my neighbors, and my coaches, the only stats I’m associated with are goals, appearances and caps. I would be doing myself, my family and my community an injustice if I didn’t stand here today with my voice and my platform and ask you for help.”Rashford has said that Johnson didn’t respond to a personal letter sent in September, so perhaps expect a staged public meeting to take place in a matter of days. However, it is highly unlikely that Rashford will allow himself to be used for a cheap political stunt. He has already denied that, contrary to some Tory suggestions, Johnson has been in touch with him.> Hmm, unless he’s referring to the call we had following the u-turn in June?... https://t.co/QSwmyETN7x> > — Marcus Rashford MBE (@MarcusRashford) October 26, 2020Rashford appears impervious to Tory political power-play (say one thing, do another, target the most vulnerable). In his open letter, he responded to one MP who had told him, patronizingly, that there was a benefits system to deal with food poverty. “Rest assured, I am fully aware of the Universal Credit scheme and I am fully aware that the majority of families applying are experiencing five-week delays,” Rashford said. “Universal Credit is simply not a short-term solution. I also know from talking to people that there is a two-child-per-family limit, meaning someone like my mum would only have been able to cover the cost of two of her five children.”“This is not about politics; this is about humanity,” Rashford wrote in June. “Looking at ourselves in the mirror and feeling like we did everything we could to protect those who can’t, for whatever reason or circumstance, protect themselves. Political affiliations aside, can we not all agree that no child should be going to bed hungry?”Rashford has the government on the back foot. Political observers in the U.K. say it is a matter of time before the government does a U-turn on the issue (for a second time). The more disturbing question is why it has taken a footballer to spur a nation's government to act on such a critical social issue.Read more at The Daily Beast.Get our top stories in your inbox every day. Sign up now!Daily Beast Membership: Beast Inside goes deeper on the stories that matter to you. Learn more.
For the first time ever, the giant retailer has started its sale a month early
No matter if you ride day or night, the best bike lights can increase your safety on the road
Tears fill Ephraim Osinboyejo's eyes as he recalls the idealism that drove thousands of Nigerians like him into the streets to campaign against police brutality - and the night he saw young activists gunned down. The 39-year-old businessman says he returned to Nigeria last year after two decades abroad because he wanted to help his country. When nationwide demonstrations began on Oct. 8, he volunteered to manage logistics at the main protest site in Lagos.
Dublin, Oct. 27, 2020 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides an overview of the Graft Versus Host Disease (Immunology) pipeline landscape. The pipeline guide provides comprehensive information on the therapeutics under development for Graft Versus Host Disease (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Graft Versus Host Disease (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Graft Versus Host Disease (GVHD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 1, 12, 38, 15, 3, 39, 8 and 1 respectively. Similarly, the Universities portfolio in Phase III, Phase I, Preclinical and Discovery stages comprises 1, 3, 13 and 1 molecules, respectively.The pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision-making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.Scope of the report: The pipeline guide provides a snapshot of the global therapeutic landscape of Graft Versus Host Disease.The pipeline guide reviews pipeline therapeutics by companies and universities/research institutes based on information derived from company and industry-specific sources.The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.The pipeline guide reviews key companies involved in Graft Versus Host Disease (Immunology) therapeutics and enlists all their major and minor projects.The pipeline guide evaluates Graft Versus Host Disease (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.The pipeline guide encapsulates all the dormant and discontinued pipeline projects. Key Topics Covered: Graft Versus Host Disease (GVHD) - Overview Graft Versus Host Disease (GVHD) - Therapeutics Development Graft Versus Host Disease (GVHD) - Therapeutics Assessment Graft Versus Host Disease (GVHD) - Companies Involved in Therapeutics Development Graft Versus Host Disease (GVHD) - Drug Profiles Graft Versus Host Disease (GVHD) - Dormant Projects Graft Versus Host Disease (GVHD) - Discontinued Products Graft Versus Host Disease (GVHD) - Product Development Milestones Companies Mentioned AbbVie IncAdienne Pharma & BiotechAltruBio IncAmgen IncAnaptysBio Incapceth Biopharma GmbHASC Therapeutics IncAstraZeneca PlcAthersys IncAutolus Therapeutics PlcBellicum Pharmaceuticals IncBiocon LtdBiogen IncBioIncept LLCBioTheryX IncBlueRock TherapeuticsBoryung ViGenCell IncBristol-Myers Squibb CoCapricor Therapeutics IncCellect Biotechnology LtdCellective BioTherapy IncCellix Bio Pvt LtdCheckPoint Immunology IncClinigen Group PlcCSL LtdCTI BioPharma CorpCytodyn IncCytopeutics Pte LtdDaewoong Pharmaceutical Co LtdDualogics CorpEducell dooEli Lilly and CoenGene IncEnlivex Therapeutics LtdEvive BiotechExCellThera IncF. Hoffmann-La Roche LtdFate Therapeutics IncFujifilm Holdings CorpGenentech USA IncGigaGen IncGlaxoSmithKline PlcGlia LLCHumanigen InciCELL Biotechnology Co LtdImmplacateImmune Modulation IncImmuneTarget IncImstem Biotechnology IncIncyte CorpInspyr Therapeutics IncJazz Pharmaceuticals PlcJN Biosciences LLCKadmon Corp LLCKalytera Therapeutics IncKamada LtdKiniksa Pharmaceuticals LtdKymab LtdLG Chem LtdMaaT PharmaMachavert Pharmaceuticals LLCMagenta Therapeutics IncMallinckrodt PlcMedexus Pharmaceuticals IncMedicenna Therapeutics CorpMediolanum farmaceutici SpAMedsenic SASMereo Biopharma Group PlcMesoblast LtdMillennium Pharmaceuticals IncMitoImmune Therapeutics IncNapaJen Pharma IncNeovii Pharmaceuticals AGNurix Therapeutics IncOncoImmune IncOSE ImmunotherapeuticsPanorama Research IncPfizer IncPlatinum Biotech (Beijing) Co LtdPluristem Therapeutics IncPrecision Biosciences IncREGiMMUNE CorpSCM lifescience Co LtdSeattle Genetics IncSecura Bio IncSeres Therapeutics IncShenzhen Chipscreen Biosciences Co LtdSTERO Biotechs LtdStingInn LLCSuzhou Connect Biopharmaceuticals LtdSuzhou Zelgen Biopharmaceutical Co LtdSyndax Pharmaceuticals IncSynthetic Biologics IncTakeda Pharmaceutical Co LtdTargazyme IncTCF GmbHTeraImmune IncTGV Laboratories IncUnited BioPharma IncVault Pharma IncVisterra IncXenikos BVXenothera SASXL-protein GmbH For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/pchon6 About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Her confirmation marks a major political victory for Trump just days before the presidential election.
The U.S. Federal Trade Commission needs new powers to protect the struggling U.S. local news industry from unfair competition from large technology companies, a senior U.S. lawmaker said. Maria Cantwell, the top Democrat on the Senate Commerce Committee, said in a report released Tuesday that "local news has been hijacked by a few large news aggregation platforms, most notably Google and Facebook, which have become the dominant players in online advertising."
Kate Winslet's role in Avatar 2 remains something of a mystery, but now we've got a glimpse of her sub-aquatic stunt work with a new on-set picture.
Euro zone banks tightened access to credit in the third quarter of the year and expected to continue doing so in the remainder of the year as they grew more worried about the impact of the coronavirus pandemic, a European Central Bank survey showed on Tuesday. Banks tightened their criteria for approving loans to enterprises and consumers as well as the terms and conditions on the credit they did approve, the survey showed. "For the fourth quarter of 2020, banks expect credit standards to continue to tighten for firms, reflecting concerns around the economic recovery as some sectors remain vulnerable, as well as uncertainties around the prolongation of fiscal support measures," the ECB said in a statement.
The efforts of Rashford, Jordan Henderson and Raheem Sterling contrast to the greed from owners greed
It Says Here by Sean O'Brien review – impossibility made possibleFrom postwar London and empty afternoons to a perfect love affair, this masterly new collection is rich in beautiful phrases
Tanzanian president accused of repression on eve of election. Opposition and rights groups criticise John Magufuli, who looks on course for second term